Cadila Healthcare Limited discovers, develops, manufactures, and markets a range of healthcare products worldwide. It provides its products in various forms, including formulations, injectable, aerosols, ointments, vaccines, biologics, active pharmaceutical ingredients, etc. The company offers products in the areas of cardiovascular, gastro intestinal, respiratory, women’s healthcare, pain management, CNS, anti-infective, oncology, neuroscience, dermatology, nephrology, and chronic/lifestyle primarily under the Aten, Ocid, Deriphyllin, Pantodac, Atorva, Nucoxia, and Mifegest brands. It also provides consumer healthcare and wellness products, such as Sugar Free Gold, a sweetener; Sugar Free Natura, a sucralose based sugar substitute; Sugar Free D’lite, a healthy drink; Nutralite, a cholesterol-free table spread; and Actilife, a nutritional milk additive for adults, as well as skincare products comprising scrubs, peel-off, face wash, and soaps under its Everyuth and Dermacare brands. In addition, the company researches and develops a pipeline of 19 biologics comprising 17 biosimilars and 2 novel biological products; new drugs in cardio-metabolic, inflammation, pain, and oncology therapeutic areas; novel drug delivery systems; molecules for DMF filing and NPD molecules; and generic products, as well as solid orals, pulmonary, parenterals, suppository, topical, and oncology products. Further, it provides animal healthcare products comprising drugs, feed supplements, and vaccines for livestock, companion animals, and poultry. Additionally, the company develops vaccines that are designed to address infectious diseases, including next-generation influenza, measles-mumps-rubella-varicella, typhoid, DPT-HiB, hepatitis-B, hepatitis-A, hepatitis-E, Japanese encephalitis, and HPV. It has strategic out-licensing deal with Abbott Laboratories for the commercial supply of products. The company was founded in 1952 and is headquartered in Ahmedabad, India.
cadila healthcare ltd (CDH:Natl India)
Satellite Cross Roads
Phone: 91 79 2686 8100
Fax: 91 79 2686 2365www.zyduscadila.com
|Cipla Ltd/India||635.15 INR||-2.40|
|Piramal Enterprises Ltd||809.65 INR||+0.20|
|Ranbaxy Laboratories Ltd||612.35 INR||-3.85|
|Torrent Pharmaceuticals Ltd||1,028 INR||+6.35|
|Wockhardt Ltd||844.25 INR||+16.65|
|View Industry Companies|
Sponsored Financial Commentaries
To contact CADILA HEALTHCARE LTD, please visit www.zyduscadila.com. Company data is provided by Capital IQ. Please use this form to report any data issues.